Tim GilmerWe are on a collision course. Two opposing forces are gathering momentum like waves headed in opposite directions, and when they meet head on, chaos and confusion will prevail.

We are in an era of unprecedented medical innovation. More and more medical breakthroughs are coming into play or on the drawing board. At the cellular level, such as with stem cell implants and manipulation of brain and spinal cord resiliency (plasticity), we are seeing a growing body of successes in treating diseases and conditions that were previously considered untreatable. And at the product level, such as with exoskeletons or epidural stimulation devices — whether implanted or transcutaneous — the future holds more promise than ever before.

But an opposing force driven by a wave of economic uncertainty has been with us for a long time and is growing at an especially alarming rate. Individual states have had serious budget problems for years, but the federal funding impasse may now be even more critical. This negative wave affects NEW MOBILITY readers in at least two major ways. First, newer processes and products, no matter how beneficial they may be, are harder to finance and bring to market. Second, coverage approval from Medicare, Medicaid and private insurers is getting tighter.

Is there an answer? I’m no economic expert, but I have to believe that tax reform that frees up more tax revenue from the wealthiest co